Whenever there is a decision to be made about chemotherapy or treatment options, the EVA-PCD assay can help identify, from many comparable choices, the most effective and least toxic treatment for you. Whether you are newly diagnosed, experiencing a recurrence or your current chemotherapy is no longer effective, we can help.
Chemosensitivity Testing–What It Is and What It Isn’t
To ensure the accuracy of our results, the patient should be 2 - 4 weeks outside of any recent chemotherapy at the time of specimen collection. Recent treatment exposure may interfere with the EVA-PCD results.
Solid tumor: A minimum of 1 gm/1 cm of viable malignant tumor tissue is needed
NOTE: Needle biopsies DO NOT provide the quantity/quality of tumor required for an accurate EVA-PCD analysis.
Malignant Effusions: 500-1000 ml of heparinized, cytologically positive pleural or ascites fluid.
Blood (Leukemia) Specimen: 7 – 10 ml of peripheral blood in EDTA tube
Bone Marrow Aspirate (Leukemias and myelomas): 1 – 3 ml of heparinized bone marrow aspirate
The specimen must be received at Rational Therapeutics’ laboratory within 24 – 36 hours of collection. Contact the laboratory to order a specimen transportation kit.
Click to download information to discuss the EVA-PCD® functional profile with your physician.
Call us at 1-800-542-HELP (4357) or click on Contact Us for additional information on how you can partner with Rational Therapeutics to identify the most effective treatment based on your unique tumor makeup.
Contact the laboratory directly to order a specimen transportation kit or to review specimen requirements.